5Y Capital logo

5Y Capital

Asia, Shanghai, China, Xuhui

Description

5Y Capital, formerly known as Morningside Venture Capital, stands as a preeminent venture capital firm deeply rooted in China's innovation ecosystem. The firm underwent its rebranding in 2020, yet it carries forward a rich legacy of over two decades in identifying and nurturing groundbreaking companies. Headquartered in Xuhui, China, 5Y Capital primarily focuses its investment activities within the dynamic Chinese market, targeting disruptive businesses poised for significant growth. Its strategic emphasis lies in early to growth-stage investments across pivotal sectors, including technology, media, and telecommunications (TMT), healthcare, and consumer industries.

The firm's investment philosophy is characterized by a proactive approach to identifying visionary entrepreneurs and providing substantial capital alongside strategic guidance. 5Y Capital has a storied history of being an early backer of some of China's most influential technology giants. Notably, its portfolio includes early investments in companies like ByteDance, the parent company of TikTok, and Kuaishou, both of which have achieved massive scale and global recognition. This track record underscores 5Y Capital's acumen in spotting transformative businesses at their nascent stages.

5Y Capital has consistently demonstrated its fundraising prowess, securing significant capital commitments from limited partners globally. This financial strength enables the firm to make substantial investments and support its portfolio companies through various growth phases. For instance, the firm successfully closed its USD Fund VII at an impressive $1.5 billion in 2021, a testament to investor confidence. This followed previous successful closes, such as the Morningside China TMT Fund VI, which secured $700 million in 2019. With an extensive portfolio encompassing over 300 investments, 5Y Capital remains a highly active and influential player in the Asian venture capital landscape, committed to fostering innovation and driving value creation.

Investor Profile

5Y Capital has backed more than 108 startups, with 10 new investments in the last 12 months alone. The firm has led 25 rounds, about 23% of its total and boasts 22 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in China, United States, India.
  • Strong thematic focus on Artificial Intelligence (AI), Software, Internet.
  • Led 3 rounds in the past year.
  • Typical check size: $5M – $50M.

Stage Focus

  • Series C (23%)
  • Series A (22%)
  • Series B (21%)
  • Seed (10%)
  • Series D (6%)
  • Series E (6%)
  • Angel (4%)
  • Series Unknown (4%)
  • Series F (2%)
  • Corporate Round (1%)

Country Focus

  • China (68%)
  • United States (23%)
  • India (4%)
  • United Kingdom (2%)
  • Brazil (1%)
  • Singapore (1%)
  • Hong Kong (1%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Software
  • Internet
  • Biotechnology
  • Information Technology
  • Health Care
  • Saas
  • Apps
  • Automotive
  • Robotics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does 5Y Capital frequently co-invest with?

Shunwei Capital
Asia, Beijing, China, Beijing
Co-Investments: 8
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 14
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 9
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 10
Morningside Group
North America, Massachusetts, United States, Newton Center
Co-Investments: 10
BAI capital
Asia, Beijing, China, Beijing
Co-Investments: 8
DCM Ventures
North America, California, United States, Menlo Park
Co-Investments: 14
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 14
Tiger Global Management
North America, New York, United States, New York
Co-Investments: 8
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 21

Which angels does 5Y Capital often collaborate with?

BG
Asia, China
Shared Deals: 1
SG
North America, California, United States, San Francisco
Shared Deals: 1
EY
North America, California, United States, San Francisco
Shared Deals: 1
Gan Jie
Asia, Beijing, China
Shared Deals: 1
HB
North America, New York, United States, New York
Shared Deals: 1
Xiaopeng He
Asia, Guangdong, China, Guangzhou
Shared Deals: 1
TW
North America, New York, United States, New York
Shared Deals: 1
Adrian Cheng
Asia, Hong Kong
Shared Deals: 1
Li Zexiang
Asia, Hong Kong
Shared Deals: 1

What are some of recent deals done by 5Y Capital?

StepFun

Xuhui, Shanghai, China

StepFun is an AI technology company that develops large language models and multimodal AI systems to process and generate text.

Artificial Intelligence (AI)Foundational AIGenerative AINatural Language Processing
Series BJan 26, 2026
Amount Raised: $718,050,350

Natural Selection is a technology startup that focuses on AI-powered intelligent companions.

Artificial Intelligence (AI)
Series UnknownJan 20, 2026
Amount Raised: $42,000,000

Nature Select is a software company that develops AI memory models, multimodal interaction systems, and 3D interactive gameplay.

3D TechnologyArtificial Intelligence (AI)Software
Series UnknownJan 20, 2026
Amount Raised: $30,000,000
Humanify

Hangzhou, Zhejiang, China

Humanify focuses on developing next-generation human-like models and an AI-native operating system.

Developer Tools
SeedJan 12, 2026
Zenitar

Chengdu, Sichuan, China

Zenitar is a biomedical technology company engaged in innovative drug research and industrialization processes.

BiopharmaBiotechnologyMedicalPharmaceutical
Series CJan 12, 2026
Amount Raised: $86,017,806
Noitom Robotics

Beijing, Beijing, China

Noitom Robotics is an intelligent robot development company specializing in the sales, installation, and maintenance of industrial robots.

Robotics
SeedDec 22, 2025
Allink Biotherapeutics

Shanghai, Shanghai, China

Allink Biotherapeutics is a biopharmaceutical company that develops multi-specific antibodies for oncology and immunology treatment.

BiopharmaBiotechnologyMedicalPharmaceutical
Series ADec 16, 2025
Amount Raised: $47,000,000
Syneron

Guangzhou, Guangdong, China

Syneron is a company that using artificial intelligence and biotechnology to address two significant global challenges.

Artificial Intelligence (AI)Biotechnology
Series ADec 11, 2025
Amount Raised: $100,000,000
Extreme shell technology

Shanghai, Shanghai, China

Extreme shell technology helps in creation and development of exoskeleton equipment for consumers.

Information TechnologyManufacturing
Series BNov 27, 2025
Amount Raised: $70,000,000
YouWare

Dover, Delaware, United States

YouWare AI platform enable creators to turn ideas into living, interactive projects.

Artificial Intelligence (AI)Content CreatorsGenerative AIInformation Technology
Pre SeedNov 13, 2025
Amount Raised: $50,000,000

Find More Investors Like 5Y Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides